EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High-Dose Antibiotics in Intensive Care: A Review of Their Role in Combatting and Contributing to Antimicrobial Resistance

Galo G. Farfán-Cano, Carlos R. Cedeño-Cevallos

Microbes, Infection and Chemotherapy · 03.12.2024 · 4 · e2250

DOI: 10.54034/mic.e2250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbes, Infection and Chemotherapy, online erschienen am 03.12.2024. Verfasst von Galo G. Farfán-Cano und 1 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

High-dose antibiotic regimens are commonly employed to improve outcomes in critically ill patients with severe infections; however, their direct impact on antimicrobial resistance (AMR) remains underexplored.

Methods

This systematic review analyzed randomized controlled trials (RCTs) published between 2020 and 2024, focusing on high-dose regimens for gram-negative bacterial infections, cellulitis, and ventilated hospital-acquired bacterial pneumonia (vHABP). A comprehensive search was conducted using the Web of Science and PubMed databases, yielding four studies that met the inclusion criteria.

Results

The results suggest that while high-dose regimens reduce treatment failure and improve clinical outcomes, they are associated with higher adverse effects and may contribute to antibiotic-resistant bacteria. Notably, none of the studies directly assessed the molecular or epidemiological mechanisms linking high-dose regimens to AMR, underscoring a significant gap in the current literature.

Conclusion

Further research is required to elucidate these mechanisms and establish evidence-based guidelines that balance immediate clinical benefits with long-term public health concerns.

Zitieren

APA

Farfán-Cano, G. G., & Cedeño-Cevallos, C. R. (2024). High-Dose Antibiotics in Intensive Care: A Review of Their Role in Combatting and Contributing to Antimicrobial Resistance. Microbes, Infection and Chemotherapy, 4, e2250. https://doi.org/10.54034/mic.e2250

Vancouver

Farfán-Cano GG, Cedeño-Cevallos CR. High-Dose Antibiotics in Intensive Care: A Review of Their Role in Combatting and Contributing to Antimicrobial Resistance. Microbes, Infection and Chemotherapy. 2024;4:e2250. doi:10.54034/mic.e2250

BibTeX
@article{FarfnCano2024,
  author = {Farfán-Cano, Galo G. and Cedeño-Cevallos, Carlos R.},
  title = {High-Dose Antibiotics in Intensive Care: A Review of Their Role in Combatting and Contributing to Antimicrobial Resistance},
  journal = {Microbes, Infection and Chemotherapy},
  year = {2024},
  volume = {4},
  pages = {e2250},
  doi = {10.54034/mic.e2250}
}
Kostenlos starten →